Toxicity of antineoplastic agents in man, chromosomal aberrations antifertility effects, congenital malformations, and carcinogenic potential.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000477:Alkylating Agents / Q000009:adverse effects; D000568:Amenorrhea / Q000139:chemically induced; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002273:Carcinogens; D002869:Chromosome Aberrations; D004359:Drug Therapy, Combination; D005260:Female; D005298:Fertility / Q000187:drug effects; D005333:Fetus / Q000187:drug effects; D006689:Hodgkin Disease / Q000150:complications; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016030:Kidney Transplantation; D007938:Leukemia / Q000150:complications; D008223:Lymphoma / Q000150:complications; D008297:Male; D051379:Mice; D009378:Neoplasms, Multiple Primary / Q000139:chemically induced; D010053:Ovary / Q000187:drug effects; D010265:Paraproteinemias / Q000150:complications; D011247:Pregnancy; D051381:Rats; D013091:Spermatogenesis / Q000187:drug effects; D014184:Transplantation, Homologous
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D002273:Carcinogens; D007166:Immunosuppressive Agents